Upgrade to
ZEISS CIRRUS 5000 & HFA3

Accurately diagnose and stage glaucoma

The standard of care tools to diagnose and monitor glaucoma are an OCT and a visual field test. Both data points are important to establish a baseline and follow-up trends. Using high-performance devices such as the CIRRUS® and HFA® from ZEISS you will minimize testing time, and maximize information.

  • Visualize statistically significant changes with GPA™ for both HFA3 and CIRRUS
  • Streamline your workflow with faster data capture and more efficient analysis
  • Advancing clinical efficiency in glaucoma. CIRRUS 5000 and HFA3 data instantly combines in Glaucoma Workplace powered by FORUM® for structure/function integrated analysis.

ZEISS CIRRUS 5000

AngioPlex® OCT Angiography ushers in a new era of eye care with non-invasive imaging of retinal microvasculature—taking glaucoma and retinal disease management and treatment planning to the next level.

ZEISS HFA3 Perimeter

The gold standard of perimetry, now with SITA Faster expanded testing options and reduced patient test times.

Unable to load form.

Already have an HFA3?

Order your complimentary HFA3 v1.5 Upgrade Kit

Section 179 applicable (see www.Section179.org ), save thousands of dollars on your year-end equipment purchase.

Educational Downloads

Improving Efficiency and Workflows in Glaucoma Management with Integrated Diagnostics in my Private Practice

Douglas Liva, MD

Data Integration for Clinical Decision Making

Peter A. Karth, MD, MBA

The statements of the authors reflect only their personal opinions and experiences and do not necessarily reflect the opinion of any institution with whom they are affiliated. The authors alone are responsible for the content of their experience reported and any potential resulting infringements. Carl Zeiss Meditec AG and its affiliates do not have clinical evidence supporting the opinions and statements of the authors nor accept any responsibility or liability of the authors’ content. The authors  have a contractual or other financial relationship with Carl Zeiss Meditec and its affiliates and have received financial support.